Dr. Martin Guerrero
Psychiatry · El Paso, TX
CMS Profile ID: 224352 · NPI: 1952591935
F
Payment Grade
High payments ($100,000+). This grade reflects disclosed general payments in CMS Open Payments program year 2024 only.
Total Disclosed Payments
$497,858
Number of Payments
733
Transparency Score
1/5
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $362,946 |
| Travel and Lodging | $75,068 |
| Consulting Fee | $42,633 |
| Food and Beverage | $17,201 |
| Education | $10 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Vanda Pharmaceuticals Inc. | $177,730 |
| Neurocrine Biosciences, Inc. | $103,999 |
| Otsuka America Pharmaceutical, Inc. | $81,424 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $46,613 |
| ABBVIE INC. | $30,375 |
| E.R. Squibb & Sons, L.L.C. | $29,533 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2024 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by name or NPI on the
official CMS Open Payments portal.
What should I ask my doctor?
- Are you a paid speaker or consultant for any pharmaceutical or device company?
- Do any of your prescribing choices reflect relationships with industry?
- Is there an equivalent generic or alternative treatment?